<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="perform and validating our approach on both real-life data from" exact="Italy" post="and synthetic instances. Our results show that increased inter-regional"/>
 <result pre="used by the United Kingdomâ€™s National Health Service. Fig. 1" exact="United Kingdom" post="National Health Serviceâ€™s protocol for rRT-PCR analysis of samples"/>
 <result pre="increasing the number of tests in much of Europe, North" exact="America" post="and Asia [1], [13], [27], [43]. Therefore, health authorities"/>
 <result pre="performed. The problem is motivated by the practice employed in" exact="Italy" post="during the early period of the epidemic, of double-checking"/>
 <result pre="based on data sources relative to the COVID-19 pandemic in" exact="Italy" post="[12], [25], [28], [32], [38]. We use data for"/>
 <result pre="a shows the distribution of laboratories and reagent factories in" exact="Italy" post="[25]: dots represents labs which are officially authorised to"/>
 <result pre="testing. Fig.Â 4b reports the number of swabs analysed in" exact="Italy" post="during the period 01â€&quot;13 April, 2020, on a regional"/>
 <result pre="models, compared to the number of swabs actually tested in" exact="Italy" post="in the described period. The last row gives aggregate"/>
 <result pre="the hypotheses explained above. In particular, assuming that tests in" exact="Italy" post="were largely limited by the unavailability of reagent due"/>
 <result pre="two computational studies: the first based on real-life data from" exact="Italy" post="and the second on synthetic instances. Under the assumptions"/>
</results>
